consider therapeutic potential radiation effect modifiers necessary balance modification injury tumours different types normal tissue especially important ensure effects demonstrated preclinical experiments qualitatively quantitatively relevant radiation doses used clinical schedules radiobiology studies initially performed large single doses large fractions results predictions potential clinical benefit radiation modifier clinic used repeated small fractions NUMBER gy period weeks effects quantitatively different dose ranges variety reasons modifiers radiation effect truly dose spectrum differential effect type damage inflicted high low dose levels described linear quadratic terms lq model means modifier dose dose fraction dependence magnitude sensitization protection details dose dependence vary ratio tissue consideration furthermore tissues tumours contain mixture cells different proliferative redox characteristics influence sensitivity radiation susceptibility radiomodifier influence different subsets cells changes fractionated treatment progresses sensitive cells eradicated leaving resistant survivors overall response fractionated schedule depends critically cells resistant phase sensitive modifiable phases fraction series addition magnitude dose modification depends totally standard curve comparison reference standard different preclinical laboratory studies conventional clinical experience differences considered moving laboratory clinic effect different factors considered using linear quadratic model dissect components examples provided demonstrate clinical relevance dose modifying assortment alpha beta